南宫NG28(中国)

Be the most trusted biotech company

2024-03-07

Henlius to Present Exploratory Biomarker Analysis Results of the Pivotal Clinical Trial ASTRUM-005 of Serplulimab at AACR 2024
2024-03-05

Henlius’ Trastuzumab Plots Southeast Asia Expansion, to Enter Thailand and Philippines
2024-03-04

Henlius Forecasts Profit in 2023: Achieving first full year of profitability, and ushering in a new phase of high-quality development
2024-02-29

Henlius Adalimumab Biosimilar Received sNDA Acceptance Notification from the NMPA
2024-02-19

ASTRUM-004 Featured on the Cover of Cancer Cell
2024-02-01

Henlius Announces Successful Completion of Phase 1 PK Similarity Clinical Study of Denosumab HLX14
2024-01-25

First International Shipment of HANSIZHUANG
2024-01-17

Results from Clinical Trials of Two Henlius’ Novel Products Released at ASCO GI 2024
2024-01-11

Henlius and Sermonix Announce Strategic Collaboration and Exclusive License Agreements for Novel Endocrine Therapy Lasofoxifene

1
...
6
7
8
9
10